GlassScriptPhysician profile
Jamie W Cox
NPI 1811974413
$2,986.77
in general payments reported to CMS, 2019-2025
25 companies · $563 in 2025
The $563 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $197 · 2021: $226 · 2022: $426 · 2023: $674 · 2024: $691 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,928.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $543.59 | 2020-2025 | Iodosorb Ointment 40g USA, Collagenase Santyl, Oasis |
| Solventum Corporation | $501.99 | 2024-2025 | Activ.A.C., Promogran Prisma, V.A.C. Dermatac |
| Next Science LLC | $325.81 | 2023 | Blastx, Xperience, Surgx |
| Kerecis Limited | $319.02 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Abbvie INC. | $257.46 | 2021-2023 | Teflaro |
| Mimedx Group, INC. | $152.88 | 2024-2025 | |
| Melinta Therapeutics, LLC | $124.16 | 2019-2024 | Kimyrsa, Orbactiv, Rezzayo |
| Paratek Pharmaceuticals, INC. | $99.11 | 2024 | Nuzyra |
| Organogenesis INC. | $98.26 | 2020-2025 | Puraply Wound Matrix |
| Glaxosmithkline, LLC. | $79.95 | 2019 | |
| Tactile Systems Technology INC | $73.99 | 2020-2024 | Entre Plus, Flexitouch Plus |
| Novo Nordisk INC | $56.52 | 2019 | |
| Urgo Medical North America, LLC | $52.45 | 2024-2025 | Urgok2, Urgoclean Ag |
| Allergan, INC. | $52.41 | 2019-2020 | |
| Medline Industries LP | $40.51 | 2019-2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $32.88 | 2021-2022 | |
| Convatec INC. | $32.15 | 2023 | |
| Integra Lifesciences Corporation | $23.99 | 2024 | Tcc-Ez |
| Molnlycke Health Care US, LLC | $21.42 | 2022 | |
| Nevro Corp. | $20.77 | 2024 | Senza |
| Aroa Biosurgery Incorporated | $18.77 | 2020 | |
| Reapplix INC. | $15.92 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.61 | 2019 | |
| Kci USA, INC. | $15.04 | 2020 | |
| Alnylam Pharmaceuticals INC. | $12.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.